Full Text View
Tabular View
No Study Results Posted
Related Studies
Zoledronate, Calcium, and Vitamin D in Preventing Bone Loss in Women Receiving Adjuvant Chemotherapy for Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00022087   Information provided by National Cancer Institute (NCI)
First Received: August 10, 2001   Last Updated: May 9, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Breast Cancer
Osteoporosis
Additional conditions recognized in this trial
Breast Neoplasms
More general conditions related to this trial
Bone Diseases
Bone Diseases, Metabolic
Breast Diseases
Musculoskeletal Diseases
Neoplasms
Neoplasms by Site
Skin Diseases
Interventions listed in this trial
calcium carbonate
calcium citrate
cholecalciferol
calcium gluconate
zoledronic acid
adjuvant therapy
Additional drug interventions recognized in this trial
Adjuvants, Immunologic
Calcium, Dietary
More general drug interventions related to this trial
Antacids
Bone Density Conservation Agents
Growth Substances
Immunologic Factors
Micronutrients
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Vitamins
Sponsors listed in this trial
Cancer and Leukemia Group B
National Cancer Institute (NCI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services